Direktorat Registrasi ObatValid

XARELTO

Claim this product
BPOM Number
DKI0951602517A1
Approved
21 November 2024
Expiry
27 January 2029
Form
TABLET SALUT SELAPUT; 10 MG

About This Registration

XARELTO is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI0951602517A1. Its current registration status is Valid, with the licence valid until 27 January 2029. The product is registered to BAYER INDONESIA and manufactured by BAYER INDONESIA - INDONESIA. BPOM first approved this registration in January 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS. 1 BLISTER @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

RIVAROXABAN

Market Intelligence

Owner Portfolio
BAYER INDONESIA holds 95 BPOM registrations
Manufacturer Scale
BAYER INDONESIA - INDONESIA produces 81 registered products
Registration Age
Registered for 2 years, 6 months

FDA Cross-Reference

via openFDA
Generic Name
RIVAROXABAN
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1